Spironolactone Orion

Medicinal product

(Invented) name

Spironolactone Orion

Active substance (s)

Spironolaktonas

Strength

25 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C03DA01, Spironolactone

Marketing authorisation holder

Orion Corporation, Suomija

Date of authorisation

2012-03-07

Date of renewal

2016-01-04

Documents

2842 Spironolactone Orion RPP 2024 11 29.docx

2842 Pakuotės lapelis 2024 11 29.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

FI/H/0773/001/MR

Marketing authorisation procedure

Savitarpio pripažinimo procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Spironolaktonas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
47140	60954	1060954	plačiakaklis indas	N30		Receptinis	LT/1/12/2842/001	Tiekiama	-	-	No	-	-
51452	65347	1065347	plačiakaklis indas	N100		Receptinis	LT/1/12/2842/002	Netiekiama	-	-	No	-	-
54278	68269	1068269	plačiakaklis indas	N50		Receptinis	LT/1/12/2842/007	Netiekiama	-	-	No	-	-
54279	68270	1068270	plačiakaklis indas	N250		Receptinis	LT/1/12/2842/008	Netiekiama	-	-	No	-	-
115946	102048	1102048	lizdinė plokštelė	N30		Receptinis	LT/1/12/2842/011	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2016-01-04	Perregistruotas
2012-03-07	Registruotas